DELAWARE | 001-32410 | 98-0420726 | ||
(State or other jurisdiction
of incorporation) |
(Commission File
Number) |
(IRS Employer
Identification No.) |
CELANESE CORPORATION
By:
/s/Steven M. Sterin
Name:
Steven M. Sterin
Title:
Vice President and
Corporate Controller
|
Celanese Corporation | |
|
Investor Relations | |
Corporate News Release
|
1601 West LBJ Freeway | |
|
Dallas, Texas 75234-6034 | |
|
||
|
Mark Oberle | |
|
Phone: +1 972 443 4464 |
| Net sales increase 10% from prior year to $1,685 million | ||
| Operating profit up 111% to $200 million | ||
| Diluted EPS is $0.64, up 146% | ||
| Adjusted EPS is $0.79, up 61% | ||
| Operating EBITDA increases 28% to $322 million | ||
| Net debt decreases to $2,936 million |
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
(in $ millions, except per share data) | 2006 | 2005 | 2006 | 2005 | ||||||||||||
Net sales
|
1,685 | 1,526 | 5,000 | 4,493 | ||||||||||||
Operating profit
|
200 | 95 | 562 | 406 | ||||||||||||
Net earnings
|
109 | 45 | 329 | 102 | ||||||||||||
Basic EPS
|
$ | 0.67 | $ | 0.26 | $ | 2.02 | $ | 0.62 | ||||||||
Diluted EPS
|
$ | 0.64 | $ | 0.26 | $ | 1.92 | $ | 0.62 | ||||||||
Adjusted EPS *
|
$ | 0.79 | $ | 0.49 | $ | 2.23 | $ | 1.66 | ||||||||
Operating EBITDA *
|
322 | 252 | 936 | 802 |
* | Non-U.S. GAAP measures. See reconciliation in tables 1 and 6. |
Page 2 of 14
| Announced agreement to acquire Acetate Products Limited, the cellulose acetate flake, tow and film activities of Corsadi BV. The proposed acquisition, subject to customary regulatory approvals, is consistent with the companys goal of improving upon its cost effective, highly reliable supply to the global acetate market. | ||
| Celanese moved to an independent board of directors with the election of two new independent directors. The board now has a total of 11 directors, including six independent directors. | ||
| Effective in the fourth quarter of 2006, the company expects to lower the borrowing costs on its senior credit facility by |
Page 3 of 14
reducing the margin over LIBOR from 2.00% to 1.75% on approximately $1.3 billion of the U.S. dollar denominated portion of the Term Loans due to overall leverage ratio improvement. |
Page 4 of 14
Page 5 of 14
Page 6 of 14
| Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of |
Page 7 of 14
other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for managements discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants. | |||
| Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information. | ||
| Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the companys capital structure. Our management and credit analysts use net debt to evaluate the companys capital structure and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information. |
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
(in $ millions, except per share data) | 2006 | 2005 | 2006 | 2005 | |||||||||||||
Net sales
|
1,685 | 1,526 | 5,000 | 4,493 | |||||||||||||
Cost of sales
|
(1,318 | ) | (1,240 | ) | (3,916 | ) | (3,491 | ) | |||||||||
Gross profit
|
367 | 286 | 1,084 | 1,002 | |||||||||||||
|
|||||||||||||||||
Selling, general and administrative expenses
|
(147 | ) | (144 | ) | (452 | ) | (438 | ) | |||||||||
Research and development expenses
|
(16 | ) | (22 | ) | (52 | ) | (68 | ) | |||||||||
Other charges
|
0 | (24 | ) | (12 | ) | (89 | ) | ||||||||||
Foreign exchange (loss), net
|
(2 | ) | (2 | ) | (3 | ) | | ||||||||||
Gain (loss) on disposition of assets, net
|
(2 | ) | 1 | (3 | ) | (1 | ) | ||||||||||
Operating profit
|
200 | 95 | 562 | 406 | |||||||||||||
|
|||||||||||||||||
Equity in net earnings of affiliates
|
20 | 21 | 59 | 48 | |||||||||||||
Interest expense
|
(74 | ) | (72 | ) | (218 | ) | (316 | ) | |||||||||
Interest income
|
9 | 7 | 26 | 31 | |||||||||||||
Other income, net
|
26 | 26 | 61 | 47 | |||||||||||||
Earnings from continuing operations
before tax and minority interests
|
181 | 77 | 490 | 216 | |||||||||||||
|
|||||||||||||||||
Income tax provision
|
(72 | ) | (27 | ) | (159 | ) | (79 | ) | |||||||||
Earnings from continuing operations
before minority interests
|
109 | 50 | 331 | 137 | |||||||||||||
|
|||||||||||||||||
Minority interests
|
(2 | ) | (3 | ) | (3 | ) | (41 | ) | |||||||||
Earnings from continuing operations
|
107 | 47 | 328 | 96 | |||||||||||||
|
|||||||||||||||||
Earnings (loss) from operation of discontinued operations
|
2 | (2 | ) | 1 | 6 | ||||||||||||
Net earnings
|
109 | 45 | 329 | 102 | |||||||||||||
|
|||||||||||||||||
Cumulative preferred stock dividend declared
|
(3 | ) | (3 | ) | (8 | ) | (7 | ) | |||||||||
Net earnings available to common
shareholders
|
106 | 42 | 321 | 95 | |||||||||||||
|
|||||||||||||||||
Earnings (loss) per common share basic:
|
|||||||||||||||||
Continuing operations
|
$ | 0.66 | $ | 0.27 | $ | 2.01 | $ | 0.58 | |||||||||
Discontinued operations
|
0.01 | (0.01 | ) | 0.01 | 0.04 | ||||||||||||
Net earnings available to common shareholders
|
$ | 0.67 | $ | 0.26 | $ | 2.02 | $ | 0.62 | |||||||||
|
|||||||||||||||||
Earnings (loss) per common share diluted:
|
|||||||||||||||||
Continuing operations
|
$ | 0.63 | $ | 0.27 | $ | 1.91 | $ | 0.58 | |||||||||
Discontinued operations
|
0.01 | (0.01 | ) | 0.01 | 0.04 | ||||||||||||
Net earnings available to common shareholders
|
$ | 0.64 | $ | 0.26 | $ | 1.92 | $ | 0.62 | |||||||||
|
|||||||||||||||||
Weighted average shares basic
|
158.6 | 158.5 | 158.6 | 153.0 | |||||||||||||
Weighted average shares diluted
|
171.2 | 171.9 | 171.6 | 153.5 | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
(in $ millions) | 2006 | 2005 | 2006 | 2005 | |||||||||||||
Net Sales
|
|||||||||||||||||
Chemical Products
|
1,206 | 1,091 | 3,558 | 3,203 | |||||||||||||
Technical Polymers Ticona
|
230 | 212 | 691 | 674 | |||||||||||||
Acetate Products
|
171 | 162 | 514 | 499 | |||||||||||||
Performance Products
|
41 | 46 | 138 | 140 | |||||||||||||
Other Activities *
|
69 | 55 | 198 | 75 | |||||||||||||
Intersegment eliminations
|
(32 | ) | (40 | ) | (99 | ) | (98 | ) | |||||||||
Total
|
1,685 | 1,526 | 5,000 | 4,493 | |||||||||||||
|
|||||||||||||||||
Operating Profit (Loss)
|
|||||||||||||||||
Chemical Products
|
170 | 101 | 475 | 436 | |||||||||||||
Technical Polymers Ticona
|
37 | 18 | 116 | 62 | |||||||||||||
Acetate Products
|
23 | 4 | 75 | 24 | |||||||||||||
Performance Products
|
10 | 13 | 43 | 41 | |||||||||||||
Other Activities *
|
(40 | ) | (41 | ) | (147 | ) | (157 | ) | |||||||||
Total
|
200 | 95 | 562 | 406 | |||||||||||||
|
|||||||||||||||||
Equity Earnings and Other Income/(Expense) **
|
|||||||||||||||||
Chemical Products
|
22 | 36 | 47 | 44 | |||||||||||||
Technical Polymers Ticona
|
13 | 15 | 42 | 43 | |||||||||||||
Acetate Products
|
| | 21 | 2 | |||||||||||||
Performance Products
|
| (2 | ) | 1 | (2 | ) | |||||||||||
Other Activities *
|
11 | (2 | ) | 9 | 8 | ||||||||||||
Total
|
46 | 47 | 120 | 95 | |||||||||||||
|
|||||||||||||||||
Other Charges and Other Adjustments ***
|
|||||||||||||||||
Chemical Products
|
3 | 19 | 10 | 23 | |||||||||||||
Technical Polymers Ticona
|
| 4 | (4 | ) | 25 | ||||||||||||
Acetate Products
|
| 9 | | 10 | |||||||||||||
Performance Products
|
| 1 | | 1 | |||||||||||||
Other Activities *
|
3 | 7 | 35 | 42 | |||||||||||||
Total
|
6 | 40 | 41 | 101 | |||||||||||||
|
|||||||||||||||||
Depreciation and Amortization Expense
|
|||||||||||||||||
Chemical Products
|
39 | 45 | 118 | 118 | |||||||||||||
Technical Polymers Ticona
|
16 | 13 | 48 | 42 | |||||||||||||
Acetate Products
|
6 | 3 | 18 | 21 | |||||||||||||
Performance Products
|
3 | 4 | 11 | 10 | |||||||||||||
Other Activities *
|
6 | 5 | 18 | 9 | |||||||||||||
Total
|
70 | 70 | 213 | 200 | |||||||||||||
|
|||||||||||||||||
Operating EBITDA
|
|||||||||||||||||
Chemical Products
|
234 | 201 | 650 | 621 | |||||||||||||
Technical Polymers Ticona
|
66 | 50 | 202 | 172 | |||||||||||||
Acetate Products
|
29 | 16 | 114 | 57 | |||||||||||||
Performance Products
|
13 | 16 | 55 | 50 | |||||||||||||
Other Activities *
|
(20 | ) | (31 | ) | (85 | ) | (98 | ) | |||||||||
Total
|
322 | 252 | 936 | 802 | |||||||||||||
* | Other Activities primarily includes corporate selling, general and administrative expenses and the results from AT Plastics and captive insurance companies. | |
** | Includes equity earnings from affiliates and other income/(expense), which is primarily dividends from cost investments. | |
*** | Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations. |
Page 11 of 14
(in percent)
Volume
Price
Currency
Other
Total
3
%
5
%
2
%
0
%
10
%
10
%
-3
%
2
%
-1
%
8
%
0
%
6
%
0
%
0
%
6
%
-6
%
-6
%
1
%
0
%
-11
%
4
%
4
%
2
%
0
%
10
%
(in percent) | Volume | Price | Currency | Other* | Total | |||||||||||||||
Chemical Products
|
1 | % | 4 | % | 0 | % | 6 | % | 11 | % | ||||||||||
Technical Polymers Ticona
|
6 | % | -1 | % | -2 | % | -1 | % | 2 | % | ||||||||||
Acetate Products
|
-4 | % | 7 | % | 0 | % | 0 | % | 3 | % | ||||||||||
Performance Products
|
11 | % | -10 | % | -2 | % | 0 | % | -1 | % | ||||||||||
Total Company
|
2 | % | 3 | % | 0 | % | 6 | % | 11 | % | ||||||||||
* | Primarily represents net sales from the Acetex business (Chemical Products), the absence of sales related to the COC divestiture (Ticona), and AT Plastics and captive insurance companies (Total Company). |
Nine Months Ended | ||||||||
September 30, | ||||||||
(in $ millions) | 2006 | 2005 | ||||||
Net cash provided by operating activities
|
415 | 513 | ||||||
Net cash (used in) investing activities
|
(193 | ) | (778 | ) | ||||
Net cash (used in) financing activities
|
(109 | ) | (78 | ) | ||||
Exchange rate effects on cash
|
10 | (94 | ) | |||||
Cash and cash equivalents at beginning of period
|
390 | 838 | ||||||
Cash and cash equivalents at end of period
|
513 | 401 | ||||||
Page 12 of 14
Three Months Ended
Nine Months Ended
September 30,
September 30,
(in $ millions)
2006
2005
2006
2005
17
14
53
60
16
33
62
54
33
47
115
114
September 30,
December 31,
(in $ millions)
2006
2005
205
155
3,244
3,282
3,449
3,437
513
390
2,936
3,047
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
(in $ millions, except per share data) | 2006 | 2005 | 2006 | 2005 | |||||||||||||
Earnings from continuing operations
before tax and minority interests
|
181 | 77 | 490 | 216 | |||||||||||||
Non-GAAP Adjustments:
|
|||||||||||||||||
Other charges and other adjustments *
|
6 | 40 | 41 | 101 | |||||||||||||
Refinancing costs
|
| | | 102 | |||||||||||||
Adjusted earnings from continuing operations
before tax and minority interests
|
187 | 117 | 531 | 419 | |||||||||||||
Income tax provision on adjusted earnings **
|
(47 | ) | (28 | ) | (143 | ) | (102 | ) | |||||||||
Minority interests
|
(2 | ) | (3 | ) | (3 | ) | (41 | ) | |||||||||
Earnings from discontinued operations, net of tax and adjustments ***
|
(2 | ) | (2 | ) | (3 | ) | 6 | ||||||||||
Preferred dividends
|
(3 | ) | (3 | ) | (8 | ) | (7 | ) | |||||||||
Adjusted net earnings available to common shareholders
|
133 | 81 | 374 | 275 | |||||||||||||
Add back: Preferred dividends
|
3 | 3 | 8 | 7 | |||||||||||||
Adjusted net earnings for diluted adjusted EPS
|
136 | 84 | 382 | 282 | |||||||||||||
|
|||||||||||||||||
Diluted shares (millions)
|
|||||||||||||||||
Weighted average shares outstanding
|
158.6 | 158.5 | 158.6 | 158.5 | |||||||||||||
Assumed conversion of Preferred Shares
|
12.0 | 12.0 | 12.0 | 10.9 | |||||||||||||
Assumed conversion of stock options
|
0.6 | 1.4 | 1.0 | 0.5 | |||||||||||||
Total diluted shares
|
171.2 | 171.9 | 171.6 | 169.9 | |||||||||||||
Adjusted EPS from continuing operations
|
0.80 | 0.50 | 2.25 | 1.62 | |||||||||||||
|
|||||||||||||||||
Earnings per common share from discontinued operations, net of
adjustments
|
(0.01 | ) | (0.01 | ) | (0.02 | ) | 0.04 | ||||||||||
Adjusted EPS
|
0.79 | 0.49 | 2.23 | 1.66 | |||||||||||||
* | See Table 7 for details | |
** | The U.S. GAAP tax rate for the three months ended September 30, 2006 is 40% and nine months ended September 30, 2006 is 32%. The companys adjusted tax rate for the three months ended September 30, 2006 is 25% and the resulting year to date adjusted tax rate is 27%. The difference between our US GAAP taxes and our adjusted taxes are due to: (i) the favorable impact of purchase accounting on our net operating losses ($23 million), and (ii) the elimination of discrete tax items not related to the current period ($4 million). | |
*** | Does not include gain on sale related to discontinued operations. |
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
(in $ millions) | 2006 | 2005 | 2006 | 2005 | |||||||||||||
Employee termination benefits
|
| 8 | 11 | 16 | |||||||||||||
Plant/office closures
|
| 13 | | 15 | |||||||||||||
Total restructuring
|
| 21 | 11 | 31 | |||||||||||||
Asset impairments
|
| 1 | | 25 | |||||||||||||
Insurance recoveries associated with plumbing cases
|
| | (3 | ) | (4 | ) | |||||||||||
Other
|
| 2 | 4 | 37 | ** | ||||||||||||
Total
|
| 24 | 12 | 89 | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
(in $ millions) | 2006 | 2005 | 2006 | 2005 | |||||||||||||
Executive severance & legal costs related
to Squeeze-Out
|
5 | | 28 | | |||||||||||||
Favorable impact on non-operating foreign
exchange position
|
| | | (14 | ) | ||||||||||||
Advisor monitoring fee
|
| | | 10 | |||||||||||||
Purchase accounting for inventories
|
| 16 | | 16 | |||||||||||||
Business Optimization
|
4 | | 4 | | |||||||||||||
Other
|
(3 | ) | | (3 | ) | | |||||||||||
Total
|
6 | 16 | 29 | 12 | |||||||||||||
|
|||||||||||||||||
Total other charges and other adjustments
|
6 | 40 | 41 | 101 | |||||||||||||
* | Previously described as Special Charges | |
** | Termination of advisor monitoring fee | |
*** | These items are included in net earnings but not included in other charges. |
Dave Weidman, President and CEO John J. Gallagher III, Executive Vice President and CFO Celanese 3Q 2006 Earnings Conference Call / Webcast Tuesday, October 31, 2006 9:00 a.m. CT |
Forward Looking Statements, Reconciliation and Use of Non-GAAP Measures to U.S. GAAP |
Dave Weidman President and Chief Executive Officer |
Celanese Corporation Q3 2006 Highlights Quarterly net sales increase 10% from prior year Operating profit in Q3 up 111% on strong volumes, higher margins and fewer other charges and adjustments Adjusted EPS in Q3 up 61% to $0.79 Operating EBITDA in Q3 increases 28% to $322 million in $ millions (except EPS) 3rd Qtr 2006 3rd Qtr 2005 9M YTD 2006 9M YTD 2005 Net Sales 1,685 1,526 5,000 4,493 Adjusted EPS $0.79 $0.49 $2.23 $1.66 Operating EBITDA 322 252 936 802 7 |
Integrated Hybrid Business Model Drives Shareholder Value Performance Products Continues to deliver stable earnings and strong cash flow 9 Chemical Products Continued robust demand Profitable growth in Asia Ticona Innovation and market penetration fuel high growth Acetate Products Revitalization efforts on track Proposed Acetate Products Limited acquisition |
John J. Gallagher III Executive Vice President and Chief Financial Officer |
Celanese Corporation Financial Highlights Based on diluted shares of 171.2 million as of Sept. 30, 2006, and a 25% effective tax rate Based on diluted shares of 171.9 million as of Sept. 30, 2005, and a 24% effective tax rate in $ millions (except EPS) 3rd Qtr 2006 3rd Qtr 2005 Net Sales 1,685 1,526 Operating Profit 200 95 Net Earnings 109 45 Special Items Other Charges/Adjustments 6 40 Adjusted EPS $0.791 $0.49 2 Operating EBITDA 322 252 13 |
Third Quarter 2006: Strong earnings on continued high utilization across industry Significantly improved operating profit as increases in volume and price outpaced higher raw material costs Impact of Celanese specific opportunities on operating margin Reduced dividends from Saudi cost investment (IBN Sina) Strong integrated chain of acetyl products in $ millions 3rd Qtr 2006 Net Sales $1,206 up 11% Operating EBITDA $234 up 16% Chemical Products 15 |
Third Quarter 2006: Increased penetration in key customer segments Operating margins expanded on increased volume and reduced spending, offsetting higher raw material and energy costs Product/customer mix slightly affect year over year pricing Healthy demand in Europe Focus on increased growth through innovation in $ millions 3rd Qtr 2006 Net Sales $230 up 8% Operating EBITDA $66 up 32% Ticona Technical Polymers 17 |
Revitalization still on track China venture tow expansion complete, moving forward on flake expansion Performance Products Stable earnings healthy sweetener demand Lower volume driven by timing of sales in the carbonated beverage season; no change in underlying fundamentals Attractive, cash generating businesses Acetate Products in $ millions 3rd Qtr 2006 Net Sales $171 up 6% Operating EBITDA $29 up 81% in $ millions 3rd Qtr 2006 Net Sales $41 down 11% Operating EBITDA $13 down 19% 19 |
Significant Contributions Continue from Equity and Cost Investments Q3 2005 Q3 2006 YTD 2005 YTD 2006 Q3 2005 Q3 2006 YTD 2005 YTD 2006 YTD 2006: Cash flow approximates earnings impact FY 2006 guidance: Income and cash impact similar to 2005 Income Statement Cash Flow 21 |
Capitalization Cash Senior Credit Term Loan Senior Credit Revolver Floating Rate Term Loan Total Senior Debt Senior Sub Notes ($) Senior Sub Notes (*) Other Debt Total Cash Pay Debt Discount Notes Series A Discount Notes Series B Total Debt Shareholders' Equity Total Capitalization Net Debt(Total Debt Less Cash) 390 1,708 - - 1,708 800 153 397 3,058 73 306 3,437 235 3,672 3,047 Dec 31, 2005 (in $millions) * Translated at 1.266 - effective date Sept 30, 2006 513 1,613 - - 1,613 800 164 463 3,040 79 330 3,449 546 3,995 2,936 Sept 30, 2006 23 |
2006 Business Outlook Chemical Products Favorable industry dynamics Continued strong global demand Ticona Increasing penetration in key customer segments Improved global demand Positive impact of COC sale continues Acetate Products Improving earnings with revitalization on track On path to targeted profitability levels Performance Products Planned price declines continue Underlying business fundamentals unchanged 2006 Adjusted EPS Guidance $2.70 to $2.80 Forecasted tax rate for 2006 of 27% 25 |
2006 Guidance Adjusted EPS: $2.70 to $2.80 Depreciation/Amortization $275 - $300 million Cash Interest Expense $230 - $250 million Effective Tax Rate 27% Capital Expenditures $200 - $250 million CE Equity 158.6 million shares common stock outstanding 0.6 million stock option grants* 12 million shares convertible preferred * Based on total of 11 million stock option grants valued using the Treasury Method as of Sept. 30,2006. 27 |
Appendix |
Reg G: Reconciliation of Diluted Adjusted EPS 31 |
Reg G: Reconciliation of Net Debt 33 |
Reg G: Reconciliation of Other Charges and Other Adjustments 35 |
Reg G: Reconciliation of Operating EBITDA 37 |